| Product Code: ETC9686306 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Heart Failure Diagnostics/Therapeutics Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Heart Failure Diagnostics/Therapeutics Market - Industry Life Cycle |
3.4 Thailand Heart Failure Diagnostics/Therapeutics Market - Porter's Five Forces |
3.5 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.6 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume Share, By Tests, 2021 & 2031F |
4 Thailand Heart Failure Diagnostics/Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of heart failure in Thailand |
4.2.2 Growing awareness about early diagnosis and treatment options |
4.2.3 Technological advancements in diagnostic and therapeutic tools |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in rural areas |
4.3.2 High cost of advanced diagnostics and therapeutics |
4.3.3 Regulatory challenges in the approval process for new treatments |
5 Thailand Heart Failure Diagnostics/Therapeutics Market Trends |
6 Thailand Heart Failure Diagnostics/Therapeutics Market, By Types |
6.1 Thailand Heart Failure Diagnostics/Therapeutics Market, By Therapy |
6.1.1 Overview and Analysis |
6.1.2 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Therapy, 2021- 2031F |
6.1.3 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Cardiac Resynchronization Therapy, 2021- 2031F |
6.1.4 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Ventricular Assist Devices, 2021- 2031F |
6.1.5 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Counterpulsation Implants, 2021- 2031F |
6.1.6 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Heart Failure Surgery, 2021- 2031F |
6.1.7 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Fluid Reduction (Renal Impairment), 2021- 2031F |
6.1.8 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Neurostimulation, 2021- 2031F |
6.1.9 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Central Sleep Apnea, 2021- 2031F |
6.1.10 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Central Sleep Apnea, 2021- 2031F |
6.2 Thailand Heart Failure Diagnostics/Therapeutics Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By ECG Systems, 2021- 2031F |
6.2.3 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Holter Monitors, 2021- 2031F |
6.2.4 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Event Monitors, 2021- 2031F |
6.2.5 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Implantable Loop Recorders, 2021- 2031F |
6.3 Thailand Heart Failure Diagnostics/Therapeutics Market, By Tests |
6.3.1 Overview and Analysis |
6.3.2 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.3.3 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Chest X Ray, 2021- 2031F |
6.3.4 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Electrocardiogram, 2021- 2031F |
6.3.5 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Echocardiogram, 2021- 2031F |
6.3.6 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Stress Test, 2021- 2031F |
6.3.7 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging, 2021- 2031F |
6.3.8 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Myocardial Biopsy, 2021- 2031F |
6.3.9 Thailand Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Myocardial Biopsy, 2021- 2031F |
7 Thailand Heart Failure Diagnostics/Therapeutics Market Import-Export Trade Statistics |
7.1 Thailand Heart Failure Diagnostics/Therapeutics Market Export to Major Countries |
7.2 Thailand Heart Failure Diagnostics/Therapeutics Market Imports from Major Countries |
8 Thailand Heart Failure Diagnostics/Therapeutics Market Key Performance Indicators |
8.1 Average time to diagnosis of heart failure |
8.2 Adoption rate of new diagnostic technologies |
8.3 Patient adherence to prescribed treatment regimens |
8.4 Number of healthcare facilities offering heart failure diagnostics and therapeutics |
8.5 Rate of hospital readmissions for heart failure patients |
9 Thailand Heart Failure Diagnostics/Therapeutics Market - Opportunity Assessment |
9.1 Thailand Heart Failure Diagnostics/Therapeutics Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.2 Thailand Heart Failure Diagnostics/Therapeutics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Thailand Heart Failure Diagnostics/Therapeutics Market Opportunity Assessment, By Tests, 2021 & 2031F |
10 Thailand Heart Failure Diagnostics/Therapeutics Market - Competitive Landscape |
10.1 Thailand Heart Failure Diagnostics/Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Thailand Heart Failure Diagnostics/Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here